Skip to content

Compliance with drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne

Compliance with drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: The ACTUO observational prospective multicenter cohort trial in 643 patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN14257026
Enrollment
600
Registered
2015-07-16
Start date
2011-10-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild to moderate acne Skin and Connective Tissue Diseases

Interventions

The study was carried out in more than 600 subjects with mild-to-moderate acne with facial involvement. Prescribed treatments were: 1. Specific anti acne drugs: topical retinoids, topical antiseptics

Sponsors

Isdin SA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Mild to moderate acne necessitating topical treatments with retinoid or antibiotics

Exclusion criteria

Exclusion criteria: Severe acne

Design outcomes

Primary

MeasureTime frame
Evaluation of the impact of adherence and compliance to the treatments on the clinical outcome in patients with mild to moderate acne.

Secondary

MeasureTime frame
Evaluation of the impact of the use of specific adjuvant treatments (facial cleansing, emollient moisturizing and lenitive specific topical products) on adherence level and entity of the clinical outcome obtained. Acne severity was assessed at each visit with a 5-point score system (from 0 to 4), absolute count of lesions and percentage of patient reaching a =50% reduction in lesion numbers. Adherence and Compliance were evaluated at visit 2 and visit 3 by means of validated 4-item questionnaire (ECOB) with a dichotomous classification: good adherence/compliance (ECOB score 4) and poor adherence/compliance (ECOB score <4). Poor compliance to treatment was defined as a different to expected answer on the ECOB questionnaire.a negative answer to question number 2 or number 3 of ECOB questionnaire.

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 15, 2026